Back
Pharming Group NV Vs. Okta, Inc. Industry Stock Comparison
Sell
48
PHAR
Pharming Group NV
Last Price:
$17.91
Seasonality Move:
-2.42%
Sell
47
OKTA
Okta, Inc.
Last Price:
$88.60
Seasonality Move:
15.75%
Sell
48
Pharming Group NV (PHAR)
is a Sell
Is Pharming Group NV a Buy, Sell or Hold?
-
The current Pharming Group NV [PHAR] share price is $17.80. The Score for PHAR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
PHAR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Okta, Inc. (OKTA)
is a Sell
Is Okta, Inc. a Buy, Sell or Hold?
-
The current Okta, Inc. [OKTA] share price is $88.61. The Score for OKTA is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
OKTA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PHAR Stock Price Chart
What is Pharming Group NV's stock price today?
-
The Pharming Group NV share price today is $17.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAR is experiencing slight selling pressure.
OKTA Stock Price Chart
What is Okta, Inc.'s stock price today?
-
The Okta, Inc. share price today is $88.61The current trend is moderately bullish and OKTA is experiencing slight buying pressure.
PHAR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.78 | Buy |
| Relative Strength Index (14 RSI): | 57.12 | Buy |
| Chaikin Money Flow: | -5110 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.35 - 17.63) | Buy |
| Bollinger Bands (100): | (13.18 - 16.6) | Buy |
OKTA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.21 | Buy |
| Relative Strength Index (14 RSI): | 53.82 | Buy |
| Chaikin Money Flow: | 363908 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (81.67 - 90.27) | Buy |
| Bollinger Bands (100): | (85.01 - 92.83) | Sell |
PHAR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.12 | Buy |
| 20-day SMA: | 17.01 | Buy |
| 50-day SMA: | 15.84 | Buy |
| 200-day SMA: | 12.33 | Buy |
| 8-day EMA: | 14.45 | Buy |
| 20-day EMA: | 8.72 | Buy |
| 50-day EMA: | 4.21 | Buy |
| 200-day EMA: | 1.16 | Buy |
OKTA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 89.56 | Sell |
| 20-day SMA: | 87.57 | Buy |
| 50-day SMA: | 86.31 | Buy |
| 200-day SMA: | 96.9 | Sell |
| 8-day EMA: | 89.08 | Sell |
| 20-day EMA: | 87.9 | Buy |
| 50-day EMA: | 87.51 | Buy |
| 200-day EMA: | 91.73 | Sell |
Pharming Group NV Earnings Growth & PHAR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.04 per share.
Okta, Inc. Earnings Growth & OKTA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.07 per share, an increase this year of $1.29 per share, and an increase next year of $0.66 per share.
Pharming Group NV Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Okta, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||